argenx SE (NAS:ARGX)
$ 356.01 -3.47 (-0.97%) Market Cap: 21.22 Bil Enterprise Value: 18.74 Bil PE Ratio: 0 PB Ratio: 5.39 GF Score: 74/100

Q4 2018 argenx SE Earnings Call Transcript

Feb 28, 2019 / 02:00PM GMT
Release Date Price: $133.29 (-0.59%)
Operator

Welcome to argenx Fourth Quarter 2018 Business Update and Full Year Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Beth DelGiacco, Vice President Investor Relations at argenx.

Beth DelGiacco
argenx SE - VP of IR - US

Thank you. Our press release with our fourth quarter business update and full year 2018 financial results became available earlier today and can be found on the News and Events section of the company's website at argenx.com.

Before we start, I'd like to go to Slide 2 to remind you that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. argenx is not under any obligation to update statements regarding the future or to conform these statements in relation to actual results unless this is required by law.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot